Association between XPO5 rs11077 polymorphism and cancer susceptibility: a meta-analysis of 7284 cases and 8511 controls
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-4.13811Keywords:
cancer, meta-analysis, risk, XPO5Abstract
Summary. Aim: Several studies evaluated the association between rs11077 polymorphism located in the 3’UTR of the XPO5 gene and cancer susceptibility. We conducted a meta-analysis to assess the impact of XPO5 rs11077 polymorphism on cancer risk. Materials and Methods: The online databases were searched for relevant case-control studies published up to July 2018. 15 articles of 16 studies, with totally 7284 cancer cases and 8511 healthy controls, were eligible for inclusion in the meta-analysis. The data were extracted from the eligible studies and were processed using Stata 14.1 and Revman 5.3 software. Pooled estimates of odds ratio with 95% confidence intervals were used to evaluate the strength of association between XPO5 rs11077 and cancer risk. Results: Overall, our finding showed no significant association between XPO5 rs11077 variant and overall cancer risk, either performed subgroup analysis by cancer types and ethnic groups in all genetic model. Conclusion: The findings did not support an association between rs11077 variant and cancer risk. Due to small sample sizes particularly in stratified analysis, further large-scale well designed studies between this polymorphism and cancer risk are warranted.
References
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359–86.
Siegel RL, Miller KD, Jemal A. Cancer Statistics 2017. CA Cancer J Clin 2017; 67: 7–30.
Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008; 359: 2143–53.
Hassanzarei S, Hashemi M, Sattarifard H, et al. Genetic polymorphisms of HOTAIR gene are associated with the risk of breast cancer in a sample of southeast Iranian population. Tumour Biol 2017; 39: 1010428317727539.
Ryan BM. microRNAs in cancer susceptibility. Adv Cancer Res 2017; 135: 151–71.
Creugny A, Fender A, Pfeffer S. Regulation of primary microRNA processing. FEBS Lett 2018; 592: 1980–96.
Esquela-Kerscher A, Slack FJ. OncomiRs — microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–69.
Lund E, Guttinger S, Calado A, et al. Nuclear export of microRNA precursors. Science 2004; 303: 95–8.
Kim JO, Bae J, Kim J, et al. Association of microRNA biogenesis genes polymorphisms with ischemic stroke susceptibility and post-stroke mortality. J Stroke 2018; 20: 110–21.
Georges M, Coppieters W, Charlier C. Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr Opin Genet Dev 2007; 17: 166–76.
Buas MF, Onstad L, Levine DM, et al. MiRNA-related SNPs and risk of esophageal adenocarcinoma and Barrett’s esophagus: post genome-wide association analysis in the BEACON consortium. PLoS One 2015; 10: e0128617.
Cho SH, Ko JJ, Kim JO, et al. 3’-UTR polymorphisms in the MiRNA machinery genes DROSHA, DICER1, RAN, and XPO5 are associated with colorectal cancer risk in a Korean population. PLoS One 2015; 10: e0131125.
Ding C, Li C, Wang H, et al. A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer. Onco Targets Ther 2013; 6: 877–81.
Horikawa Y, Wood CG, Yang H, et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 2008; 14: 7956–62.
Kim JS, Choi YY, Jin G, et al. Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study. Mol Carcinog 2010; 49: 913–21.
Kim MN, Kim JO, Lee SM, et al. Variation in the Dicer and RAN genes are associated with survival in patients with hepatocellular carcinoma. PLoS One 2016; 11: e0162279.
Osuch-Wojcikiewicz E, Bruzgielewicz A, Niemczyk K, et al. Association of polymorphic variants of miRNA processing genes with larynx cancer risk in a Polish population. Biomed Res Int 2015; 2015: 298378.
Sung H, Lee KM, Choi JY, et al. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea. Breast Cancer Res Treat 2011; 130: 939–51.
Wen J, Gao Q, Wang N, et al. Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer. Medicine (Baltimore) 2017; 96: e6351.
Xie Y, Wang Y, Zhao Y, et al. Single-nucleotide polymorphisms of microRNA processing machinery genes are associated with risk for gastric cancer. Onco Targets Ther 2015; 8: 567–71.
Yang H, Dinney CP, Ye Y, et al. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 2008; 68: 2530–7.
Ye Y, Wang KK, Gu J, et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 2008; 1: 460–9.
Zhao Y, Du Y, Zhao S, et al. Single-nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer. Onco Targets Ther 2015; 8: 421–5.
Yao S, Graham K, Shen J, et al. Genetic variants in microRNAs and breast cancer risk in African American and European American women. Breast Cancer Res Treat 2013; 141: 447–59.
Thakkar DN, Palugulla S, Selvarajan S, et al. Frequency distribution of BLMH, XPO5 and HFE gene polymorphisms in the South Indian population and their association with Hodgkin Lymphoma. Int J Biol Markers 2018; 33: 514–19.
Alizadeh J, Zeki AA, Mirzaei N, et al. Mevalonate cascade inhibition by simvastatin induces the intrinsic apoptosis pathway via depletion of isoprenoids in tumor cells. Sci Rep 2017; 7: 44841.
Ghavami S, Shojaei S, Yeganeh B, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol 2014; 112: 24–49.
Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516–7.
Ott CA, Linck L, Kremmer E, et al. Induction of exportin-5 expression during melanoma development supports the cellular behavior of human malignant melanoma cells. Oncotarget 2016; 7: 62292–304.
Khan M, Khan Z, Uddin Y, et al. Evaluating the oncogenic and tumor suppressor role of XPO5 in different tissue tumor types. Asian Pac J Cancer Prev 2018; 19: 1119–25.
Hoti N, Yang S, Aiyetan P, et al. Overexpression of exportin-5 overrides the inhibitory effect of miRNAs regulation control and stabilize proteins via posttranslation modifications in prostate cancer. Neoplasia 2017; 19: 817–29.
Li Y, Wang X, He B, et al. Downregulation and tumor-suppressive role of XPO5 in hepatocellular carcinoma. Mol Cell Biochem 2016; 415: 197–205.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
